Table of Content

1 Prophylactic HIV Drug Market Overview
1.1 Prophylactic HIV Drug Product Scope
1.2 Prophylactic HIV Drug Segment by Type
1.2.1 Global Prophylactic HIV Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
1.2.3 Integrase Inhibitor
1.3 Prophylactic HIV Drug Segment by Application
1.3.1 Global Prophylactic HIV Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Prophylactic HIV Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Prophylactic HIV Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Prophylactic HIV Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Prophylactic HIV Drug Price Trends (2016-2027)

2 Prophylactic HIV Drug Estimates and Forecasts by Region
2.1 Global Prophylactic HIV Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Prophylactic HIV Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Prophylactic HIV Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Prophylactic HIV Drug Revenue Market Share by Region (2016-2021)
2.3 Global Prophylactic HIV Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Prophylactic HIV Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Prophylactic HIV Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Prophylactic HIV Drug Estimates and Projections (2016-2027)
2.4.2 Europe Prophylactic HIV Drug Estimates and Projections (2016-2027)
2.4.3 China Prophylactic HIV Drug Estimates and Projections (2016-2027)
2.4.4 Japan Prophylactic HIV Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Prophylactic HIV Drug Estimates and Projections (2016-2027)
2.4.6 India Prophylactic HIV Drug Estimates and Projections (2016-2027)
3 Global Prophylactic HIV Drug Competition Landscape by Players
3.1 Global Top Prophylactic HIV Drug Players by Sales (2016-2021)
3.2 Global Top Prophylactic HIV Drug Players by Revenue (2016-2021)
3.3 Global Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prophylactic HIV Drug as of 2020)
3.4 Global Prophylactic HIV Drug Average Price by Company (2016-2021)
3.5 Manufacturers Prophylactic HIV Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Prophylactic HIV Drug Market Size by Type
4.1 Global Prophylactic HIV Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Prophylactic HIV Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Prophylactic HIV Drug Price by Type (2016-2021)
4.2 Global Prophylactic HIV Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Prophylactic HIV Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Prophylactic HIV Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Prophylactic HIV Drug Price Forecast by Type (2022-2027)
5 Global Prophylactic HIV Drug Market Size by Application
5.1 Global Prophylactic HIV Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Prophylactic HIV Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Prophylactic HIV Drug Price by Application (2016-2021)
5.2 Global Prophylactic HIV Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Prophylactic HIV Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Prophylactic HIV Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Prophylactic HIV Drug Price Forecast by Application (2022-2027)

6 North America Prophylactic HIV Drug Market Facts & Figures
6.1 North America Prophylactic HIV Drug Sales by Company
6.1.1 North America Prophylactic HIV Drug Sales by Company (2016-2021)
6.1.2 North America Prophylactic HIV Drug Revenue by Company (2016-2021)
6.2 North America Prophylactic HIV Drug Sales Breakdown by Type
6.2.1 North America Prophylactic HIV Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Prophylactic HIV Drug Sales Breakdown by Type (2022-2027)
6.3 North America Prophylactic HIV Drug Sales Breakdown by Application
6.3.1 North America Prophylactic HIV Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Prophylactic HIV Drug Sales Breakdown by Application (2022-2027)

7 Europe Prophylactic HIV Drug Market Facts & Figures
7.1 Europe Prophylactic HIV Drug Sales by Company
7.1.1 Europe Prophylactic HIV Drug Sales by Company (2016-2021)
7.1.2 Europe Prophylactic HIV Drug Revenue by Company (2016-2021)
7.2 Europe Prophylactic HIV Drug Sales Breakdown by Type
7.2.1 Europe Prophylactic HIV Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Prophylactic HIV Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Prophylactic HIV Drug Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)

8 China Prophylactic HIV Drug Market Facts & Figures
8.1 China Prophylactic HIV Drug Sales by Company
8.1.1 China Prophylactic HIV Drug Sales by Company (2016-2021)
8.1.2 China Prophylactic HIV Drug Revenue by Company (2016-2021)
8.2 China Prophylactic HIV Drug Sales Breakdown by Type
8.2.1 China Prophylactic HIV Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Prophylactic HIV Drug Sales Breakdown by Type (2022-2027)
8.3 China Prophylactic HIV Drug Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Prophylactic HIV Drug Market Facts & Figures
9.1 Japan Prophylactic HIV Drug Sales by Company
9.1.1 Japan Prophylactic HIV Drug Sales by Company (2016-2021)
9.1.2 Japan Prophylactic HIV Drug Revenue by Company (2016-2021)
9.2 Japan Prophylactic HIV Drug Sales Breakdown by Type
9.2.1 Japan Prophylactic HIV Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Prophylactic HIV Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Prophylactic HIV Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Prophylactic HIV Drug Market Facts & Figures
10.1 Southeast Asia Prophylactic HIV Drug Sales by Company
10.1.1 Southeast Asia Prophylactic HIV Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Prophylactic HIV Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Prophylactic HIV Drug Sales Breakdown by Type
10.2.1 Southeast Asia Prophylactic HIV Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Prophylactic HIV Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Prophylactic HIV Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Prophylactic HIV Drug Market Facts & Figures
11.1 India Prophylactic HIV Drug Sales by Company
11.1.1 India Prophylactic HIV Drug Sales by Company (2016-2021)
11.1.2 India Prophylactic HIV Drug Revenue by Company (2016-2021)
11.2 India Prophylactic HIV Drug Sales Breakdown by Type
11.2.1 India Prophylactic HIV Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Prophylactic HIV Drug Sales Breakdown by Type (2022-2027)
11.3 India Prophylactic HIV Drug Sales Breakdown by Application
11.3.1 India Prophylactic HIV Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Prophylactic HIV Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Prophylactic HIV Drug Business
12.1 Gilead Sciences
12.1.1 Gilead Sciences Corporation Information
12.1.2 Gilead Sciences Business Overview
12.1.3 Gilead Sciences Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Sciences Prophylactic HIV Drug Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Prophylactic HIV Drug Products Offered
12.2.5 Merck Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Business Overview
12.3.3 Mylan Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Prophylactic HIV Drug Products Offered
12.3.5 Mylan Recent Development
12.4 Cipla
12.4.1 Cipla Corporation Information
12.4.2 Cipla Business Overview
12.4.3 Cipla Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Cipla Prophylactic HIV Drug Products Offered
12.4.5 Cipla Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Corporation Information
12.5.2 Bristol-Myers Squibb Business Overview
12.5.3 Bristol-Myers Squibb Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bristol-Myers Squibb Prophylactic HIV Drug Products Offered
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Business Overview
12.6.3 Roche Prophylactic HIV Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Roche Prophylactic HIV Drug Products Offered
12.6.5 Roche Recent Development
...

13 Prophylactic HIV Drug Manufacturing Cost Analysis
13.1 Prophylactic HIV Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Prophylactic HIV Drug
13.4 Prophylactic HIV Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Prophylactic HIV Drug Distributors List
14.3 Prophylactic HIV Drug Customers

15 Market Dynamics
15.1 Prophylactic HIV Drug Market Trends
15.2 Prophylactic HIV Drug Drivers
15.3 Prophylactic HIV Drug Market Challenges
15.4 Prophylactic HIV Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Prophylactic HIV Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Prophylactic HIV Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Prophylactic HIV Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Prophylactic HIV Drug Sales (K Units) by Region (2016-2021)
Table 5. Global Prophylactic HIV Drug Sales Market Share by Region (2016-2021)
Table 6. Global Prophylactic HIV Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Prophylactic HIV Drug Revenue Share by Region (2016-2021)
Table 8. Global Prophylactic HIV Drug Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Prophylactic HIV Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Prophylactic HIV Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Prophylactic HIV Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Prophylactic HIV Drug Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Prophylactic HIV Drug Sales Share by Company (2016-2021)
Table 14. Global Prophylactic HIV Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Prophylactic HIV Drug Revenue Share by Company (2016-2021)
Table 16. Global Prophylactic HIV Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prophylactic HIV Drug as of 2020)
Table 17. Global Prophylactic HIV Drug Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Prophylactic HIV Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Prophylactic HIV Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Prophylactic HIV Drug Sales (K Units) by Type (2016-2021)
Table 22. Global Prophylactic HIV Drug Sales Share by Type (2016-2021)
Table 23. Global Prophylactic HIV Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Prophylactic HIV Drug Price (USD/Unit) by Type (2016-2021)
Table 25. Global Prophylactic HIV Drug Sales Share by Type (2022-2027)
Table 26. Global Prophylactic HIV Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Prophylactic HIV Drug Revenue Share by Type (2022-2027)
Table 28. Global Prophylactic HIV Drug Price (USD/Unit) by Type (2022-2027)
Table 29. Global Prophylactic HIV Drug Sales (K Units) by Application (2016-2021)
Table 30. Global Prophylactic HIV Drug Sales Share by Application (2016-2021)
Table 31. Global Prophylactic HIV Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Prophylactic HIV Drug Price (USD/Unit) by Application (2016-2021)
Table 33. Global Prophylactic HIV Drug Sales (K Units) by Application (2022-2027)
Table 34. Global Prophylactic HIV Drug Sales Share by Application (2022-2027)
Table 35. Global Prophylactic HIV Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Prophylactic HIV Drug Revenue Share by Application (2022-2027)
Table 37. Global Prophylactic HIV Drug Price (USD/Unit) by Application (2022-2027)
Table 38. North America Prophylactic HIV Drug Sales (K Units) by Company (2016-2021)
Table 39. North America Prophylactic HIV Drug Sales Market Share by Company (2016-2021)
Table 40. North America Prophylactic HIV Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Prophylactic HIV Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Prophylactic HIV Drug Sales by Type (2016-2021) & (K Units)
Table 43. North America Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
Table 44. North America Prophylactic HIV Drug Sales by Type (2022-2027) & (K Units)
Table 45. North America Prophylactic HIV Drug Sales Market Share by Type (2022-2027)
Table 46. North America Prophylactic HIV Drug Sales by Application (2016-2021) & (K Units)
Table 47. North America Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
Table 48. North America Prophylactic HIV Drug Sales by Application (2022-2027) & (K Units)
Table 49. North America Prophylactic HIV Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Prophylactic HIV Drug Sales (K Units) by Company (2016-2021)
Table 51. Europe Prophylactic HIV Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Prophylactic HIV Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Prophylactic HIV Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Prophylactic HIV Drug Sales by Type (2016-2021) & (K Units)
Table 55. Europe Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Prophylactic HIV Drug Sales by Type (2022-2027) & (K Units)
Table 57. Europe Prophylactic HIV Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Prophylactic HIV Drug Sales by Application (2016-2021) & (K Units)
Table 59. Europe Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Prophylactic HIV Drug Sales by Application (2022-2027) & (K Units)
Table 61. Europe Prophylactic HIV Drug Sales Market Share by Application (2022-2027)
Table 62. China Prophylactic HIV Drug Sales (K Units) by Company (2016-2021)
Table 63. China Prophylactic HIV Drug Sales Market Share by Company (2016-2021)
Table 64. China Prophylactic HIV Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Prophylactic HIV Drug Revenue Market Share by Company (2016-2021)
Table 66. China Prophylactic HIV Drug Sales by Type (2016-2021) & (K Units)
Table 67. China Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
Table 68. China Prophylactic HIV Drug Sales by Type (2022-2027) & (K Units)
Table 69. China Prophylactic HIV Drug Sales Market Share by Type (2022-2027)
Table 70. China Prophylactic HIV Drug Sales by Application (2016-2021) & (K Units)
Table 71. China Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
Table 72. China Prophylactic HIV Drug Sales by Application (2022-2027) & (K Units)
Table 73. China Prophylactic HIV Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Prophylactic HIV Drug Sales (K Units) by Company (2016-2021)
Table 75. Japan Prophylactic HIV Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Prophylactic HIV Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Prophylactic HIV Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Prophylactic HIV Drug Sales by Type (2016-2021) & (K Units)
Table 79. Japan Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Prophylactic HIV Drug Sales by Type (2022-2027) & (K Units)
Table 81. Japan Prophylactic HIV Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Prophylactic HIV Drug Sales by Application (2016-2021) & (K Units)
Table 83. Japan Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Prophylactic HIV Drug Sales by Application (2022-2027) & (K Units)
Table 85. Japan Prophylactic HIV Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Prophylactic HIV Drug Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Prophylactic HIV Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Prophylactic HIV Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Prophylactic HIV Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Prophylactic HIV Drug Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Prophylactic HIV Drug Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Prophylactic HIV Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Prophylactic HIV Drug Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Prophylactic HIV Drug Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Prophylactic HIV Drug Sales Market Share by Application (2022-2027)
Table 98. India Prophylactic HIV Drug Sales (K Units) by Company (2016-2021)
Table 99. India Prophylactic HIV Drug Sales Market Share by Company (2016-2021)
Table 100. India Prophylactic HIV Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Prophylactic HIV Drug Revenue Market Share by Company (2016-2021)
Table 102. India Prophylactic HIV Drug Sales by Type (2016-2021) & (K Units)
Table 103. India Prophylactic HIV Drug Sales Market Share by Type (2016-2021)
Table 104. India Prophylactic HIV Drug Sales by Type (2022-2027) & (K Units)
Table 105. India Prophylactic HIV Drug Sales Market Share by Type (2022-2027)
Table 106. India Prophylactic HIV Drug Sales by Application (2016-2021) & (K Units)
Table 107. India Prophylactic HIV Drug Sales Market Share by Application (2016-2021)
Table 108. India Prophylactic HIV Drug Sales by Application (2022-2027) & (K Units)
Table 109. India Prophylactic HIV Drug Sales Market Share by Application (2022-2027)
Table 110. Gilead Sciences Corporation Information
Table 111. Gilead Sciences Description and Business Overview
Table 112. Gilead Sciences Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Gilead Sciences Prophylactic HIV Drug Product
Table 114. Gilead Sciences Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Merck Prophylactic HIV Drug Product
Table 119. Merck Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Business Overview
Table 122. Mylan Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Mylan Prophylactic HIV Drug Product
Table 124. Mylan Recent Development
Table 125. Cipla Corporation Information
Table 126. Cipla Description and Business Overview
Table 127. Cipla Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Cipla Prophylactic HIV Drug Product
Table 129. Cipla Recent Development
Table 130. Bristol-Myers Squibb Corporation Information
Table 131. Bristol-Myers Squibb Description and Business Overview
Table 132. Bristol-Myers Squibb Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Bristol-Myers Squibb Prophylactic HIV Drug Product
Table 134. Bristol-Myers Squibb Recent Development
Table 135. Roche Corporation Information
Table 136. Roche Description and Business Overview
Table 137. Roche Prophylactic HIV Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Roche Prophylactic HIV Drug Product
Table 139. Roche Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Prophylactic HIV Drug Distributors List
Table 143. Prophylactic HIV Drug Customers List
Table 144. Prophylactic HIV Drug Market Trends
Table 145. Prophylactic HIV Drug Market Drivers
Table 146. Prophylactic HIV Drug Market Challenges
Table 147. Prophylactic HIV Drug Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Prophylactic HIV Drug Product Picture
Figure 2. Global Prophylactic HIV Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Prophylactic HIV Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Pharmacy Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Online Pharmacy Examples
Figure 9. Global Prophylactic HIV Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Prophylactic HIV Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Prophylactic HIV Drug Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Prophylactic HIV Drug Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Prophylactic HIV Drug Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Prophylactic HIV Drug Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Prophylactic HIV Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Prophylactic HIV Drug Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Prophylactic HIV Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Prophylactic HIV Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Prophylactic HIV Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Prophylactic HIV Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Prophylactic HIV Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Prophylactic HIV Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Prophylactic HIV Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Prophylactic HIV Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Prophylactic HIV Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Prophylactic HIV Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Prophylactic HIV Drug Players Market Share by Revenue in Prophylactic HIV Drug: 2016 & 2020
Figure 28. Prophylactic HIV Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Prophylactic HIV Drug Revenue Share by Type (2016-2021)
Figure 30. Global Prophylactic HIV Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Prophylactic HIV Drug Revenue Share by Application (2016-2021)
Figure 32. Global Prophylactic HIV Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Prophylactic HIV Drug Sales Market Share by Type in 2020
Figure 34. North America Prophylactic HIV Drug Sales Market Share by Application in 2020
Figure 35. Europe Prophylactic HIV Drug Sales Market Share by Type in 2020
Figure 36. Europe Prophylactic HIV Drug Sales Market Share by Application in 2020
Figure 37. China Prophylactic HIV Drug Sales Market Share by Type in 2020
Figure 38. China Prophylactic HIV Drug Sales Market Share by Application in 2020
Figure 39. Japan Prophylactic HIV Drug Sales Market Share by Type in 2020
Figure 40. Japan Prophylactic HIV Drug Sales Market Share by Application in 2020
Figure 41. Southeast Asia Prophylactic HIV Drug Sales Market Share by Type in 2020
Figure 42. Southeast Asia Prophylactic HIV Drug Sales Market Share by Application in 2020
Figure 43. India Prophylactic HIV Drug Sales Market Share by Type in 2020
Figure 44. India Prophylactic HIV Drug Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Prophylactic HIV Drug
Figure 47. Manufacturing Process Analysis of Prophylactic HIV Drug
Figure 48. Prophylactic HIV Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed